Literature DB >> 20349205

Purification and characterization of a liver-derived beta-N-Acetylhexosaminidase from marine mammal Sotalia fluviatilis.

J E Gomes Júnior1, D S L Souza, R M Nascimento, A L M Lima, J A T Melo, T L Rocha, R N G Miller, O L Franco, M F Grossi-de-Sa, L R D Abreu.   

Abstract

A beta-N-Acetylhexosaminidase (EC 3.2.1.52) was purified from hepatic extracts of Sotalia fluviatilis, order Cetacea. The protein was purified by using ammonium sulfate fractionation and four subsequent chromatographies (Biogel A 1.5 m, Chitin, Deae-Biogel and hydroxyapatite resins). After these purification steps, the enzyme was purified 380.5-fold with an 8.4% yield. The molecular mass (10 kDa) was estimated by SDS-PAGE and MALDI-TOF analysis. A Km of 2.72 mM and Vmax 9.5 x 10(-6) micromol/(min x mg) were found for this enzyme, determined by p-nitrophenyl-beta-D: -hexosaminide substrate digestion. Optimal pH and temperature for beta-N-Acetylhexosaminidase activity were 5.0 and 60 degrees C, respectively. Enzyme activity was inhibited by sodium selenate (Na(2)SeO(4)), mercuric chloride (HgCl(2)) and sodium dodecyl sulfate (C(12)H(25)SO(4)Na), and activated by zinc, calcium, barium and lithium ions. Characterization of the beta-N-Acetylhexosaminidase in Sotalia fluviatilis can be a basis for physiological studies in this species.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349205     DOI: 10.1007/s10930-010-9239-3

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  39 in total

1.  Independent adaptation to riverine habitats allowed survival of ancient cetacean lineages.

Authors:  I Cassens; S Vicario; V G Waddell; H Balchowsky; D Van Belle; W Ding; C Fan; R S Mohan; P C Simões-Lopes; R Bastida; A Meyer; M J Stanhope; M C Milinkovitch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Biotechnology of microbial xylanases: enzymology, molecular biology, and application.

Authors:  S Subramaniyan; P Prema
Journal:  Crit Rev Biotechnol       Date:  2002       Impact factor: 8.429

3.  The production, purification and characterisation of two novel alpha-D-mannosidases from Aspergillus phoenicis.

Authors:  Vasileios I Athanasopoulos; Keshavan Niranjan; Robert A Rastall
Journal:  Carbohydr Res       Date:  2005-03-21       Impact factor: 2.104

4.  Purification and characterization of two endo-beta-1,4-glucanases from mollusca, Ampullaria crossean.

Authors:  Yan-Hong Li; Rui Guo; Qiu-Yu Yin; Ming Ding; Si-Liang Zhang; Gen-Jun Xu; Fu-Kun Zhao
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2005-10       Impact factor: 3.848

Review 5.  Alpha-L-arabinofuranosidases: the potential applications in biotechnology.

Authors:  Mondher Th Numan; Narayan B Bhosle
Journal:  J Ind Microbiol Biotechnol       Date:  2005-12-30       Impact factor: 3.346

6.  Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin.

Authors:  A Schmidtchen; I M Frick; L Björck
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Purification and characterization of an extracellular exochitinase, beta-N-acetylhexosaminidase, from the fungal mycoparasite Stachybotrys elegans.

Authors:  Greg Taylor; Suha Jabaji-Hare; Pierre M Charest; Wajahatullah Khan
Journal:  Can J Microbiol       Date:  2002-04       Impact factor: 2.419

9.  Purification and characterization of an N-acetylglucosaminidase produced by a Trichoderma harzianum strain which controls Crinipellis perniciosa.

Authors:  J Lisboa De Marco; M C Valadares-Inglis; C R Felix
Journal:  Appl Microbiol Biotechnol       Date:  2003-12-13       Impact factor: 4.813

10.  Fabry disease in children and the effects of enzyme replacement treatment.

Authors:  Guillem Pintos-Morell; Michael Beck
Journal:  Eur J Pediatr       Date:  2009-02-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.